Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette S Kim

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
JCO Oncology Practice|June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO GuidelineChristina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2023
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone MarrowSam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, et al.
The Journal of Molecular Diagnostics : JMD|July 7, 2023
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid TumorsHarrison K Tsai, Tasos Gogakos, Va Lip, et al.
Cancer Cell|November 20, 2020
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid LeukemiaShruti Bhatt, Marissa S Pioso, Elyse Anne Olesinski, et al.
Blood Advances|September 23, 2022
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignanciesAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
American Journal of Clinical Pathology|October 15, 2013
Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approachAdam C Seegmiller, Annette S Kim, Claudio A Mosse, et al.
Blood Advances|October 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistanceAishath Naeem, Filippo Utro, Qing Wang, et al.
Blood|September 12, 2022
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19Peter G Miller, Geoffrey G Fell, Brody H Foy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2025
TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC)Rahul Mannan, Ying-Bei Chen, Xiaoming Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid LeukemiaAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
JCO Oncology Practice|June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO GuidelineChristina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2023
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone MarrowSam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, et al.
The Journal of Molecular Diagnostics : JMD|July 7, 2023
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid TumorsHarrison K Tsai, Tasos Gogakos, Va Lip, et al.
Cancer Cell|November 20, 2020
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid LeukemiaShruti Bhatt, Marissa S Pioso, Elyse Anne Olesinski, et al.
Blood Advances|September 23, 2022
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignanciesAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
American Journal of Clinical Pathology|October 15, 2013
Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approachAdam C Seegmiller, Annette S Kim, Claudio A Mosse, et al.
Blood Advances|October 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistanceAishath Naeem, Filippo Utro, Qing Wang, et al.
Blood|September 12, 2022
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19Peter G Miller, Geoffrey G Fell, Brody H Foy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2025
TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC)Rahul Mannan, Ying-Bei Chen, Xiaoming Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid LeukemiaAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
Pageof 11